You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 17, 2025

Drug Price Trends for NAPROXEN-ESOMEPRAZ DR


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for NAPROXEN-ESOMEPRAZ DR

Average Pharmacy Cost for NAPROXEN-ESOMEPRAZ DR

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
NAPROXEN-ESOMEPRAZ DR 375-20 MG 27241-0202-60 4.79840 EACH 2024-12-18
NAPROXEN-ESOMEPRAZ DR 375-20 MG 55111-0289-60 4.79840 EACH 2024-12-18
NAPROXEN-ESOMEPRAZ DR 375-20 MG 50228-0437-60 4.79840 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Naproxen-Esomeprazole DR

Introduction to Naproxen-Esomeprazole DR

Naproxen-Esomeprazole DR, commonly known by the brand name Vimovo, is a combination medication that combines the nonsteroidal anti-inflammatory drug (NSAID) naproxen with the proton pump inhibitor (PPI) esomeprazole. This combination is designed to treat conditions such as osteoarthritis, ankylosing spondylitis, and NSAID-induced ulcer prophylaxis, while also reducing the risk of stomach ulcers associated with NSAID use[2].

Market Size and Growth

The market for esomeprazole, which is a key component of Naproxen-Esomeprazole DR, is anticipated to experience significant growth over the coming years. The global esomeprazole market was valued at USD 1.81 billion in 2023 and is expected to grow to USD 2.87 billion by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period[1].

Key Drivers of Market Growth

Several factors are driving the growth of the esomeprazole market, which in turn influences the demand for Naproxen-Esomeprazole DR:

Increasing Aging Population

The growing elderly population is a significant driver, as older individuals are more vulnerable to gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and peptic ulcers. This demographic shift is expected to increase the demand for medications like esomeprazole[3].

Lifestyle Factors

Unhealthy eating habits, obesity, and high stress levels, particularly in regions like North America, contribute to a higher incidence of acid-related disorders. These lifestyle factors are expected to continue driving the demand for esomeprazole and its combination products[3].

Rising Prevalence of GERD and Peptic Ulcers

The increasing prevalence of GERD and peptic ulcers globally, especially in North America, is a major factor boosting the market. For instance, GERD has a prevalence rate of 20% in the United States, making it one of the most highly diagnosed digestive disorders[1].

Market Segmentation

Application

The esomeprazole market, and by extension the Naproxen-Esomeprazole DR market, is segmented based on application. The GERD segment held the largest market share in 2023 and is expected to retain its position throughout the forecast period. The peptic ulcers segment is also expected to grow rapidly due to the significant rise in peptic ulcer cases[1].

Distribution Channel

Hospitals and clinical pharmacies held a significant market share in revenue in 2023. This is attributed to the rising number of people with peptic ulcers, GERD, and other disease cases in healthcare settings. The increased accessibility of hospitals, driven by government initiatives to promote healthcare infrastructure, is expected to fuel demand for medications like Naproxen-Esomeprazole DR[1].

Regional Analysis

North America

North America dominates the global esomeprazole market, with a 39.0% market revenue share in 2023. The robust healthcare infrastructure and advanced diagnostic resources in this region contribute to the high demand for esomeprazole and its combination products. The prevalence of GERD and peptic ulcers in the United States is particularly high, driving market growth[3].

Asia Pacific

The Asia Pacific region is projected to be the fastest-growing region, driven by the growing elderly population and rising cases of gastroesophageal reflux. The increasing presence of companies producing esomeprazole in this region is expected to positively impact market growth[1].

Price Projections

The cost of Naproxen-Esomeprazole DR can vary based on the dosage and pharmacy. Here are some price points for reference:

  • For a supply of 60 tablets of Naproxen-Esomeprazole DR (20 mg-375 mg or 20 mg-500 mg), the cost is around $1,082, depending on the pharmacy[2].
  • Prices can start at $230.54 for a similar dosage, highlighting the variability in pricing across different pharmacies[5].

Discounts and Savings

To make Naproxen-Esomeprazole DR more affordable, several discount programs and coupons are available. For example, the Drugs.com Discount Card can save consumers up to 80% or more off the cost of prescription medicines, including Naproxen-Esomeprazole DR[2].

Challenges and Considerations

Cost Implications

The listing of Naproxen-Esomeprazole DR on public health schemes, such as the Pharmaceutical Benefits Scheme (PBS) in Australia, can have significant cost implications. There are concerns that the potential listing could lead to increased costs rather than savings, due to plausible scenarios of higher usage and switching from non-subsidized to subsidized use[4].

Market Strategies

Companies in the esomeprazole market, including those producing Naproxen-Esomeprazole DR, engage in various market strategies such as product innovation, product differentiation, mergers, acquisitions, partnerships, and strategic alliances to maintain their competitive edge[3].

Key Takeaways

  • The global esomeprazole market, which includes Naproxen-Esomeprazole DR, is expected to grow significantly, driven by an aging population and rising cases of GERD and peptic ulcers.
  • North America dominates the market, while the Asia Pacific region is expected to be the fastest-growing.
  • The cost of Naproxen-Esomeprazole DR varies, but discount programs and coupons can help reduce the financial burden.
  • Market strategies and cost implications are crucial factors influencing the market dynamics.

FAQs

  1. What is Naproxen-Esomeprazole DR used for? Naproxen-Esomeprazole DR is used to treat conditions such as osteoarthritis, ankylosing spondylitis, and NSAID-induced ulcer prophylaxis, while reducing the risk of stomach ulcers associated with NSAID use[2].

  2. What is the expected growth rate of the esomeprazole market? The esomeprazole market is anticipated to grow at a CAGR of 5.3% from 2024 to 2032[1].

  3. Which region dominates the global esomeprazole market? North America dominates the global esomeprazole market, with a 39.0% market revenue share in 2023[3].

  4. How does the aging population impact the esomeprazole market? The growing elderly population increases the demand for esomeprazole due to their higher vulnerability to gastrointestinal disorders such as GERD and peptic ulcers[3].

  5. What are the price ranges for Naproxen-Esomeprazole DR? Prices for Naproxen-Esomeprazole DR can range from $230.54 to over $1,082 for a supply of 60 tablets, depending on the pharmacy and dosage[2][5].

Sources

  1. Polaris Market Research: Esomeprazole Market Size, Share, Global Analysis Report 2024-2032.
  2. Drugs.com: Esomeprazole/naproxen Prices, Coupons, Copay Cards & Patient Assistance.
  3. The Brainy Insights: Esomeprazole Market Size, Trend Analysis, Insights.
  4. PBS Australia: Naproxen and Esomeprazole, tablets, 500 mg-20 mg (as esomeprazole magnesium).
  5. GoodRx: Naproxen/Esomeprazole DR Prices, Coupons & Savings Tips.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.